LBT Innovations (ASX:LBT) Growth Rank : 0 (As of Jun. 08, 2024)

View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Growth Rank?

LBT Innovations has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

LBT Innovations Growth Rank Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Anster Street, Adelaide, SA, AUS, 5000

Website

https://www.lbtinnovations.com

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines